Cumberland Pharmaceuticals Inc. (CPIX) Net margin 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) net profit margin by fiscal year — reported net income divided by reported revenue.
-6.4%FY2025 · since FY2016: -2.9% → -6.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.4% | +10.7 pp |
| FY2024 | -17.1% | -1.2 pp |
| FY2023 | -15.9% | -2.6 pp |
| FY2022 | -13.3% | -3.3 pp |
| FY2021 | -10.0% | -0.7 pp |
| FY2020 | -9.3% | +1.6 pp |
| FY2019 | -10.9% | +13.3 pp |
| FY2018 | -24.2% | -4.4 pp |
| FY2017 | -19.8% | -16.9 pp |
| FY2016 | -2.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Gross profitCPIX Gross marginCPIX Operating incomeCPIX Operating marginCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Return on equityCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Total liabilitiesCPIX Shareholders’ equityCPIX overview →